ERBB2 and breast cancer: BC is a molecularly diverse disease that can be categorized into three main groups based on molecular and histological evidence: hormone receptor-positive (HR+), human epidermal growth factor receptor 2-positive (HER2+), and triple-negative BC (TNBC).